These data are consistent with the values obtained by Wang et al. 48 and Jiang et al. 49, who in two recently published meta-analyses found values for overall HR = 0.91 CI 95% (0.63 to 1.19) and HR = 0.75 CI 95% (0.28 to 1.22) respectively for the relationship between the expression of EZH2 and survival from CRC. The gene discussed is EZH2; the disease is colorectal carcinoma.